Assessing the potential for drug-drug interactions in an accelerated throughput mode.
Drug candidates that cause pharmacokinetic drug drug interactions are less likely to become a commercial success. However, rapid, cost-effective, mechanism-based screens are available for the evaluation of the potential of drug candidates to cause drug&ndashdrug interactions. This review describes experimental designs for, and recent progress in, increasing the throughput of these screens.